CHPA issues statement on FDA's recommendations on phenylephrine
CHPA supports FDA's recommendations on phenylephrine
Linda Suydam, president of the Consumer Healthcare Products Association (CHPA), issued the following statement regarding the recommendations of the FDA's Nonprescription Drugs Advisory Committee on phenylephrine: "Phenylephrine 10 mg is safe when used according to the label and has been proven effective for nasal decongestion in multiple clinical trials. Today, the FDA's expert panel voted almost unanimously (11-1) that the existing evidence supports the effectiveness of phenylephrine at the 10-mg dose and reaffirms the results of numerous scientific studies and decades of consumer experience."
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
